TY - JOUR
T1 - Human papillomavirus DNA detection in cervical specimens by hybrid capture
T2 - Correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix
AU - Hall, Scott
AU - Lörincz, Attila
AU - Shah, Farida
AU - Sherman, Mark E.
AU - Abbas, Fouad
AU - Paull, Gerson
AU - Kurman, Robert J.
AU - Shah, Keerti V
N1 - Funding Information:
We thank cytotechnologists Diedra P. Kelly and Nae’l Soudi for their help in the review of Pap smears, and Betty Elder for her help in specimen acquisition and data collection. This work was supported in part by USPHS Grant U19 AI-38533 from the National Institutes of Health (K.V.S.).
PY - 1996/9
Y1 - 1996/9
N2 - Human papillomavirus (HPV) DNA detection in cervical specimens was correlated with cytologic and histologic diagnoses for 151 women who were referred to the Johns Hopkins Hospital colposcopy clinic for evaluation of an abnormal Pap smear. HPVs were identified as 'high-risk' or 'low-risk' by Hybrid Capture. The final disease status was categorized as high-grade squamous intraepithelial lesion (HSIL) by histology (n = 26), low-grade squamous intraepithelial lesion (LSIL) by histology (n + 43), equivocal [histology negative, cytology atypical squamous cells of undetermined significance (ASCUS) or higher, n = 42], and negative (both histology and cytology negative, n = 40). Thirty-five percent of disease-negative women and 84% of the women with biopsy-proven or equivocal disease were HPV-positive. Ninety-two percent of the HPV-positive women harbored high-risk HPVs, either high-risk HPVs alone (77%) or high-risk HPVs along with low-risk HPVs (15%). Highrisk HPVs predominated in disease-negative as well as disease-positive women. Collection of specimens with a cytobrush was more efficient for HPV DNA detection than collection by cervicovaginal lavage. Large amounts of HPV DNA correlated with presence of HSIL or LSIL. For detection of HSIL, considering only brush samples, the sensitivities of abnormal cytology (ASCUS or higher), of high-risk HPVs, and of the two combined were, respectively, 87, 93, and 100%; the corresponding specificities were 30, 30, and 20%. HPV DNA detection may be most beneficial in populations with low HPV prevalence.
AB - Human papillomavirus (HPV) DNA detection in cervical specimens was correlated with cytologic and histologic diagnoses for 151 women who were referred to the Johns Hopkins Hospital colposcopy clinic for evaluation of an abnormal Pap smear. HPVs were identified as 'high-risk' or 'low-risk' by Hybrid Capture. The final disease status was categorized as high-grade squamous intraepithelial lesion (HSIL) by histology (n = 26), low-grade squamous intraepithelial lesion (LSIL) by histology (n + 43), equivocal [histology negative, cytology atypical squamous cells of undetermined significance (ASCUS) or higher, n = 42], and negative (both histology and cytology negative, n = 40). Thirty-five percent of disease-negative women and 84% of the women with biopsy-proven or equivocal disease were HPV-positive. Ninety-two percent of the HPV-positive women harbored high-risk HPVs, either high-risk HPVs alone (77%) or high-risk HPVs along with low-risk HPVs (15%). Highrisk HPVs predominated in disease-negative as well as disease-positive women. Collection of specimens with a cytobrush was more efficient for HPV DNA detection than collection by cervicovaginal lavage. Large amounts of HPV DNA correlated with presence of HSIL or LSIL. For detection of HSIL, considering only brush samples, the sensitivities of abnormal cytology (ASCUS or higher), of high-risk HPVs, and of the two combined were, respectively, 87, 93, and 100%; the corresponding specificities were 30, 30, and 20%. HPV DNA detection may be most beneficial in populations with low HPV prevalence.
UR - http://www.scopus.com/inward/record.url?scp=0030248273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030248273&partnerID=8YFLogxK
U2 - 10.1006/gyno.1996.0248
DO - 10.1006/gyno.1996.0248
M3 - Article
C2 - 8812532
AN - SCOPUS:0030248273
SN - 0090-8258
VL - 62
SP - 353
EP - 359
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 3
ER -